Global Point-of-Care Diagnostics Kit Market
Global Point-of-Care Diagnostics Kit Market

Point-of-Care Diagnostics Kit Comprehensive Study by Type (Glucose Monitoring (Strips, Meters, and Lancets), Cardiometabolic testing, Infectious disease testing, Coagulation testing, Pregnancy and fertility testing (Pregnancy testing, and Fertility testing), Tumor / Cancer marker testing, Urinalysis testing, Cholesterol testing, Hematology testing, Drugs-of-abuse testing, Fecal occult testing, Others), Application (Cardiometabolic testing, Infectious disease testing, Nephrology testing, Drug-of-Abuse (DoA) testing, Blood glucose testing, Pregnancy testing, Cancer biomarker testing, Other), Prescription (OTC testing, Prescription-based testing), Technology (Lateral flow assays, Dipsticks, Microfluidics, Molecular diagnostics, Immunoassays, Agglutination assays, Flow-through, Solid-phase, Biosensors), End-User (Hospitals, Diagnostic centers, Research laboratories, Home-care settings, Others) Players and Region - Global Market Outlook to 2027

Point-of-Care Diagnostics Kit Market Segmented into XX Submarkets. | Forecast Years: 2022- 2027  

Apr 2022 Edition 209 Pages 219 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Point-of-Care Diagnostics Kit Market Scope
Point-of-care (PoC) diagnostics kits are medical tests kit that is performed to allow for quick analysis and outcomes. Various portable tools for glucose monitoring, infectious disease, cardio-metabolic, and urinalysis testing, among other things, are used in PoC testing. It aids in the early detection of important illnesses, resulting in a more patient-centered healthcare strategy. This type of medical testing is commonly used to provide diagnostic services to remote places where clinical laboratories are difficult to establish. As a result, vital PoC testing equipment is integrated with medical vehicles such as helicopters, air ambulances, planes, and spaceships.

The Point-of-Care Diagnostics Kit market study is segmented by Type (Glucose Monitoring (Strips, Meters, and Lancets), Cardiometabolic testing, Infectious disease testing, Coagulation testing, Pregnancy and fertility testing (Pregnancy testing, and Fertility testing), Tumor / Cancer marker testing, Urinalysis testing, Cholesterol testing, Hematology testing, Drugs-of-abuse testing, Fecal occult testing and Others), by Application (Cardiometabolic testing, Infectious disease testing, Nephrology testing, Drug-of-Abuse (DoA) testing, Blood glucose testing, Pregnancy testing, Cancer biomarker testing and Other) and major geographies with country level break-up.

Some of the companies' favored market-exploration techniques include mergers and acquisitions, expansions, investments, new service launches, and collaborations. The company is giving its fair share of the company's expansion. The market for point-of-care diagnostics is moderately competitive, with several prominent competitors. Few big firms currently dominate the market in terms of market share. Other businesses are projected to enter the market as disease frequency rises and the number of the elderly population grows. Abbott, Siemens AG, Becton, Dickinson and Company, and F. Hoffmann-La Roche Ltd are among the market's key players.

Abbott Laboratories (United States), Siemens Healthineers AG (Germany), Quidel Corporation (United States), F. Hoffman-La Roche Ltd. (Switzerland), Danaher Corporation (United States), Becton (United States), Dickinson and Company (United States), Chembio Diagnostics (United States), EKF Diagnostics (United Kingdom) and Trinity Biotech plc (Ireland) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Nova Biomedical (United States), PTS Diagnostics (United States), Sekisui Diagnostics (United States) and Thermo Fisher Scientific (United States).

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a
preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from total available market.

Segmentation Overview
AMA Research has segmented the market of Global Point-of-Care Diagnostics Kit market by Type, Application and Region.

On the basis of geography, the market of Point-of-Care Diagnostics Kit has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

In Jan 2022, Roche launched their Cobas Pulse System in countries that accept the CE Mark. Roche Diagnostics has released the latest generation of integrated point-of-care solutions for professional blood glucose management. and In Oct 2021, Thermo Fisher Scientific has acquired FDA Emergency Use Authorization (EUA) to execute COVID-19 tests with the Spectrum Solutions SpectrumDNA SDNA-1000 collection equipment, a high-throughput, automated COVID-19 testing system on the Amplitude Solution.


Market Trend
  • Blood Glucose Testing Has A High Demand in the Market
  • Increasing Research Activities for the Development of Innovative Imaging

Market Drivers
  • The Increasing Disease Prevalence among the Developing Country
  • The Rise in Geriatric Population Base Globally
  • An Increasing Number of Pathology Labs and Services with Modern Diagnostic Techniques Are Being Established

Opportunities
  • Increasing Technological Advancement in a Developing Country
  • Increasing Investment in R&D Departments

Restraints
  • The Limited Availability of Medical and Lab Testing Facilities
  • High Cost of Product Development

Challenges
  • Strict Government Regulation


Key Target Audience
Industry Association, Downstream Vendors, Marketing & Consulting firms, Venture Capitalists, Government & Regulatory Bodies and Investors

Frequently Asked Questions (FAQ):

1. Is it possible to have certain customization in the study?
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a study that suits your business objectives.

2. How big is the Point-of-Care Diagnostics Kit Market?
Yes, the study does represent market size by key business segment, application/end users and major geographies forecasted till 2027.

Report Objectives / Segmentation Covered
By Type
  • Glucose Monitoring (Strips, Meters, and Lancets)
  • Cardiometabolic testing
  • Infectious disease testing
  • Coagulation testing
  • Pregnancy and fertility testing (Pregnancy testing, and Fertility testing)
  • Tumor / Cancer marker testing
  • Urinalysis testing
  • Cholesterol testing
  • Hematology testing
  • Drugs-of-abuse testing
  • Fecal occult testing
  • Others
By Application
  • Cardiometabolic testing
  • Infectious disease testing
  • Nephrology testing
  • Drug-of-Abuse (DoA) testing
  • Blood glucose testing
  • Pregnancy testing
  • Cancer biomarker testing
  • Other
By Prescription
  • OTC testing
  • Prescription-based testing

By Technology
  • Lateral flow assays
  • Dipsticks
  • Microfluidics
  • Molecular diagnostics
  • Immunoassays
  • Agglutination assays
  • Flow-through
  • Solid-phase
  • Biosensors

By End-User
  • Hospitals
  • Diagnostic centers
  • Research laboratories
  • Home-care settings
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. The Increasing Disease Prevalence among the Developing Country
      • 3.2.2. The Rise in Geriatric Population Base Globally
      • 3.2.3. An Increasing Number of Pathology Labs and Services with Modern Diagnostic Techniques Are Being Established
    • 3.3. Market Challenges
      • 3.3.1. Strict Government Regulation
    • 3.4. Market Trends
      • 3.4.1. Blood Glucose Testing Has A High Demand in the Market
      • 3.4.2. Increasing Research Activities for the Development of Innovative Imaging
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Point-of-Care Diagnostics Kit, by Type, Application, Prescription, Technology, End-User and Region (value and price ) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global Point-of-Care Diagnostics Kit (Value)
      • 5.2.1. Global Point-of-Care Diagnostics Kit by: Type (Value)
        • 5.2.1.1. Glucose Monitoring (Strips, Meters, and Lancets)
        • 5.2.1.2. Cardiometabolic testing
        • 5.2.1.3. Infectious disease testing
        • 5.2.1.4. Coagulation testing
        • 5.2.1.5. Pregnancy and fertility testing (Pregnancy testing, and Fertility testing)
        • 5.2.1.6. Tumor / Cancer marker testing
        • 5.2.1.7. Urinalysis testing
        • 5.2.1.8. Cholesterol testing
        • 5.2.1.9. Hematology testing
        • 5.2.1.10. Drugs-of-abuse testing
        • 5.2.1.11. Fecal occult testing
        • 5.2.1.12. Others
      • 5.2.2. Global Point-of-Care Diagnostics Kit by: Application (Value)
        • 5.2.2.1. Cardiometabolic testing
        • 5.2.2.2. Infectious disease testing
        • 5.2.2.3. Nephrology testing
        • 5.2.2.4. Drug-of-Abuse (DoA) testing
        • 5.2.2.5. Blood glucose testing
        • 5.2.2.6. Pregnancy testing
        • 5.2.2.7. Cancer biomarker testing
        • 5.2.2.8. Other
      • 5.2.3. Global Point-of-Care Diagnostics Kit by: Prescription (Value)
        • 5.2.3.1. OTC testing
        • 5.2.3.2. Prescription-based testing
      • 5.2.4. Global Point-of-Care Diagnostics Kit by: End-User (Value)
        • 5.2.4.1. Hospitals
        • 5.2.4.2. Diagnostic centers
        • 5.2.4.3. Research laboratories
        • 5.2.4.4. Home-care settings
        • 5.2.4.5. Others
      • 5.2.5. Global Point-of-Care Diagnostics Kit Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Australia
          • 5.2.5.2.6. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Point-of-Care Diagnostics Kit (Price)
      • 5.3.1. Global Point-of-Care Diagnostics Kit by: Type (Price)
  • 6. Point-of-Care Diagnostics Kit: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Abbott Laboratories (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Siemens Healthineers AG (Germany)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Quidel Corporation (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. F. Hoffman-La Roche Ltd. (Switzerland)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Danaher Corporation (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Becton (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Dickinson and Company (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Chembio Diagnostics (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. EKF Diagnostics (United Kingdom)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Trinity Biotech plc (Ireland)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Point-of-Care Diagnostics Kit Sale, by Type, Application, Prescription, Technology, End-User and Region (value and price ) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global Point-of-Care Diagnostics Kit (Value)
      • 7.2.1. Global Point-of-Care Diagnostics Kit by: Type (Value)
        • 7.2.1.1. Glucose Monitoring (Strips, Meters, and Lancets)
        • 7.2.1.2. Cardiometabolic testing
        • 7.2.1.3. Infectious disease testing
        • 7.2.1.4. Coagulation testing
        • 7.2.1.5. Pregnancy and fertility testing (Pregnancy testing, and Fertility testing)
        • 7.2.1.6. Tumor / Cancer marker testing
        • 7.2.1.7. Urinalysis testing
        • 7.2.1.8. Cholesterol testing
        • 7.2.1.9. Hematology testing
        • 7.2.1.10. Drugs-of-abuse testing
        • 7.2.1.11. Fecal occult testing
        • 7.2.1.12. Others
      • 7.2.2. Global Point-of-Care Diagnostics Kit by: Application (Value)
        • 7.2.2.1. Cardiometabolic testing
        • 7.2.2.2. Infectious disease testing
        • 7.2.2.3. Nephrology testing
        • 7.2.2.4. Drug-of-Abuse (DoA) testing
        • 7.2.2.5. Blood glucose testing
        • 7.2.2.6. Pregnancy testing
        • 7.2.2.7. Cancer biomarker testing
        • 7.2.2.8. Other
      • 7.2.3. Global Point-of-Care Diagnostics Kit by: Prescription (Value)
        • 7.2.3.1. OTC testing
        • 7.2.3.2. Prescription-based testing
      • 7.2.4. Global Point-of-Care Diagnostics Kit by: End-User (Value)
        • 7.2.4.1. Hospitals
        • 7.2.4.2. Diagnostic centers
        • 7.2.4.3. Research laboratories
        • 7.2.4.4. Home-care settings
        • 7.2.4.5. Others
      • 7.2.5. Global Point-of-Care Diagnostics Kit Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Australia
          • 7.2.5.2.6. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Point-of-Care Diagnostics Kit (Price)
      • 7.3.1. Global Point-of-Care Diagnostics Kit by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Point-of-Care Diagnostics Kit: by Type(USD Million)
  • Table 2. Point-of-Care Diagnostics Kit Glucose Monitoring (Strips, Meters, and Lancets) , by Region USD Million (2016-2021)
  • Table 3. Point-of-Care Diagnostics Kit Cardiometabolic testing , by Region USD Million (2016-2021)
  • Table 4. Point-of-Care Diagnostics Kit Infectious disease testing , by Region USD Million (2016-2021)
  • Table 5. Point-of-Care Diagnostics Kit Coagulation testing , by Region USD Million (2016-2021)
  • Table 6. Point-of-Care Diagnostics Kit Pregnancy and fertility testing (Pregnancy testing, and Fertility testing) , by Region USD Million (2016-2021)
  • Table 7. Point-of-Care Diagnostics Kit Tumor / Cancer marker testing , by Region USD Million (2016-2021)
  • Table 8. Point-of-Care Diagnostics Kit Urinalysis testing , by Region USD Million (2016-2021)
  • Table 9. Point-of-Care Diagnostics Kit Cholesterol testing , by Region USD Million (2016-2021)
  • Table 10. Point-of-Care Diagnostics Kit Hematology testing , by Region USD Million (2016-2021)
  • Table 11. Point-of-Care Diagnostics Kit Drugs-of-abuse testing , by Region USD Million (2016-2021)
  • Table 12. Point-of-Care Diagnostics Kit Fecal occult testing , by Region USD Million (2016-2021)
  • Table 13. Point-of-Care Diagnostics Kit Others , by Region USD Million (2016-2021)
  • Table 14. Point-of-Care Diagnostics Kit: by Application(USD Million)
  • Table 15. Point-of-Care Diagnostics Kit Cardiometabolic testing , by Region USD Million (2016-2021)
  • Table 16. Point-of-Care Diagnostics Kit Infectious disease testing , by Region USD Million (2016-2021)
  • Table 17. Point-of-Care Diagnostics Kit Nephrology testing , by Region USD Million (2016-2021)
  • Table 18. Point-of-Care Diagnostics Kit Drug-of-Abuse (DoA) testing , by Region USD Million (2016-2021)
  • Table 19. Point-of-Care Diagnostics Kit Blood glucose testing , by Region USD Million (2016-2021)
  • Table 20. Point-of-Care Diagnostics Kit Pregnancy testing , by Region USD Million (2016-2021)
  • Table 21. Point-of-Care Diagnostics Kit Cancer biomarker testing , by Region USD Million (2016-2021)
  • Table 22. Point-of-Care Diagnostics Kit Other , by Region USD Million (2016-2021)
  • Table 23. Point-of-Care Diagnostics Kit: by Prescription(USD Million)
  • Table 24. Point-of-Care Diagnostics Kit OTC testing , by Region USD Million (2016-2021)
  • Table 25. Point-of-Care Diagnostics Kit Prescription-based testing , by Region USD Million (2016-2021)
  • Table 26. Point-of-Care Diagnostics Kit: by End-User(USD Million)
  • Table 27. Point-of-Care Diagnostics Kit Hospitals , by Region USD Million (2016-2021)
  • Table 28. Point-of-Care Diagnostics Kit Diagnostic centers , by Region USD Million (2016-2021)
  • Table 29. Point-of-Care Diagnostics Kit Research laboratories , by Region USD Million (2016-2021)
  • Table 30. Point-of-Care Diagnostics Kit Home-care settings , by Region USD Million (2016-2021)
  • Table 31. Point-of-Care Diagnostics Kit Others , by Region USD Million (2016-2021)
  • Table 32. South America Point-of-Care Diagnostics Kit, by Country USD Million (2016-2021)
  • Table 33. South America Point-of-Care Diagnostics Kit, by Type USD Million (2016-2021)
  • Table 34. South America Point-of-Care Diagnostics Kit, by Application USD Million (2016-2021)
  • Table 35. South America Point-of-Care Diagnostics Kit, by Prescription USD Million (2016-2021)
  • Table 36. South America Point-of-Care Diagnostics Kit, by Technology USD Million (2016-2021)
  • Table 37. South America Point-of-Care Diagnostics Kit, by End-User USD Million (2016-2021)
  • Table 38. Brazil Point-of-Care Diagnostics Kit, by Type USD Million (2016-2021)
  • Table 39. Brazil Point-of-Care Diagnostics Kit, by Application USD Million (2016-2021)
  • Table 40. Brazil Point-of-Care Diagnostics Kit, by Prescription USD Million (2016-2021)
  • Table 41. Brazil Point-of-Care Diagnostics Kit, by Technology USD Million (2016-2021)
  • Table 42. Brazil Point-of-Care Diagnostics Kit, by End-User USD Million (2016-2021)
  • Table 43. Argentina Point-of-Care Diagnostics Kit, by Type USD Million (2016-2021)
  • Table 44. Argentina Point-of-Care Diagnostics Kit, by Application USD Million (2016-2021)
  • Table 45. Argentina Point-of-Care Diagnostics Kit, by Prescription USD Million (2016-2021)
  • Table 46. Argentina Point-of-Care Diagnostics Kit, by Technology USD Million (2016-2021)
  • Table 47. Argentina Point-of-Care Diagnostics Kit, by End-User USD Million (2016-2021)
  • Table 48. Rest of South America Point-of-Care Diagnostics Kit, by Type USD Million (2016-2021)
  • Table 49. Rest of South America Point-of-Care Diagnostics Kit, by Application USD Million (2016-2021)
  • Table 50. Rest of South America Point-of-Care Diagnostics Kit, by Prescription USD Million (2016-2021)
  • Table 51. Rest of South America Point-of-Care Diagnostics Kit, by Technology USD Million (2016-2021)
  • Table 52. Rest of South America Point-of-Care Diagnostics Kit, by End-User USD Million (2016-2021)
  • Table 53. Asia Pacific Point-of-Care Diagnostics Kit, by Country USD Million (2016-2021)
  • Table 54. Asia Pacific Point-of-Care Diagnostics Kit, by Type USD Million (2016-2021)
  • Table 55. Asia Pacific Point-of-Care Diagnostics Kit, by Application USD Million (2016-2021)
  • Table 56. Asia Pacific Point-of-Care Diagnostics Kit, by Prescription USD Million (2016-2021)
  • Table 57. Asia Pacific Point-of-Care Diagnostics Kit, by Technology USD Million (2016-2021)
  • Table 58. Asia Pacific Point-of-Care Diagnostics Kit, by End-User USD Million (2016-2021)
  • Table 59. China Point-of-Care Diagnostics Kit, by Type USD Million (2016-2021)
  • Table 60. China Point-of-Care Diagnostics Kit, by Application USD Million (2016-2021)
  • Table 61. China Point-of-Care Diagnostics Kit, by Prescription USD Million (2016-2021)
  • Table 62. China Point-of-Care Diagnostics Kit, by Technology USD Million (2016-2021)
  • Table 63. China Point-of-Care Diagnostics Kit, by End-User USD Million (2016-2021)
  • Table 64. Japan Point-of-Care Diagnostics Kit, by Type USD Million (2016-2021)
  • Table 65. Japan Point-of-Care Diagnostics Kit, by Application USD Million (2016-2021)
  • Table 66. Japan Point-of-Care Diagnostics Kit, by Prescription USD Million (2016-2021)
  • Table 67. Japan Point-of-Care Diagnostics Kit, by Technology USD Million (2016-2021)
  • Table 68. Japan Point-of-Care Diagnostics Kit, by End-User USD Million (2016-2021)
  • Table 69. India Point-of-Care Diagnostics Kit, by Type USD Million (2016-2021)
  • Table 70. India Point-of-Care Diagnostics Kit, by Application USD Million (2016-2021)
  • Table 71. India Point-of-Care Diagnostics Kit, by Prescription USD Million (2016-2021)
  • Table 72. India Point-of-Care Diagnostics Kit, by Technology USD Million (2016-2021)
  • Table 73. India Point-of-Care Diagnostics Kit, by End-User USD Million (2016-2021)
  • Table 74. South Korea Point-of-Care Diagnostics Kit, by Type USD Million (2016-2021)
  • Table 75. South Korea Point-of-Care Diagnostics Kit, by Application USD Million (2016-2021)
  • Table 76. South Korea Point-of-Care Diagnostics Kit, by Prescription USD Million (2016-2021)
  • Table 77. South Korea Point-of-Care Diagnostics Kit, by Technology USD Million (2016-2021)
  • Table 78. South Korea Point-of-Care Diagnostics Kit, by End-User USD Million (2016-2021)
  • Table 79. Australia Point-of-Care Diagnostics Kit, by Type USD Million (2016-2021)
  • Table 80. Australia Point-of-Care Diagnostics Kit, by Application USD Million (2016-2021)
  • Table 81. Australia Point-of-Care Diagnostics Kit, by Prescription USD Million (2016-2021)
  • Table 82. Australia Point-of-Care Diagnostics Kit, by Technology USD Million (2016-2021)
  • Table 83. Australia Point-of-Care Diagnostics Kit, by End-User USD Million (2016-2021)
  • Table 84. Rest of Asia-Pacific Point-of-Care Diagnostics Kit, by Type USD Million (2016-2021)
  • Table 85. Rest of Asia-Pacific Point-of-Care Diagnostics Kit, by Application USD Million (2016-2021)
  • Table 86. Rest of Asia-Pacific Point-of-Care Diagnostics Kit, by Prescription USD Million (2016-2021)
  • Table 87. Rest of Asia-Pacific Point-of-Care Diagnostics Kit, by Technology USD Million (2016-2021)
  • Table 88. Rest of Asia-Pacific Point-of-Care Diagnostics Kit, by End-User USD Million (2016-2021)
  • Table 89. Europe Point-of-Care Diagnostics Kit, by Country USD Million (2016-2021)
  • Table 90. Europe Point-of-Care Diagnostics Kit, by Type USD Million (2016-2021)
  • Table 91. Europe Point-of-Care Diagnostics Kit, by Application USD Million (2016-2021)
  • Table 92. Europe Point-of-Care Diagnostics Kit, by Prescription USD Million (2016-2021)
  • Table 93. Europe Point-of-Care Diagnostics Kit, by Technology USD Million (2016-2021)
  • Table 94. Europe Point-of-Care Diagnostics Kit, by End-User USD Million (2016-2021)
  • Table 95. Germany Point-of-Care Diagnostics Kit, by Type USD Million (2016-2021)
  • Table 96. Germany Point-of-Care Diagnostics Kit, by Application USD Million (2016-2021)
  • Table 97. Germany Point-of-Care Diagnostics Kit, by Prescription USD Million (2016-2021)
  • Table 98. Germany Point-of-Care Diagnostics Kit, by Technology USD Million (2016-2021)
  • Table 99. Germany Point-of-Care Diagnostics Kit, by End-User USD Million (2016-2021)
  • Table 100. France Point-of-Care Diagnostics Kit, by Type USD Million (2016-2021)
  • Table 101. France Point-of-Care Diagnostics Kit, by Application USD Million (2016-2021)
  • Table 102. France Point-of-Care Diagnostics Kit, by Prescription USD Million (2016-2021)
  • Table 103. France Point-of-Care Diagnostics Kit, by Technology USD Million (2016-2021)
  • Table 104. France Point-of-Care Diagnostics Kit, by End-User USD Million (2016-2021)
  • Table 105. Italy Point-of-Care Diagnostics Kit, by Type USD Million (2016-2021)
  • Table 106. Italy Point-of-Care Diagnostics Kit, by Application USD Million (2016-2021)
  • Table 107. Italy Point-of-Care Diagnostics Kit, by Prescription USD Million (2016-2021)
  • Table 108. Italy Point-of-Care Diagnostics Kit, by Technology USD Million (2016-2021)
  • Table 109. Italy Point-of-Care Diagnostics Kit, by End-User USD Million (2016-2021)
  • Table 110. United Kingdom Point-of-Care Diagnostics Kit, by Type USD Million (2016-2021)
  • Table 111. United Kingdom Point-of-Care Diagnostics Kit, by Application USD Million (2016-2021)
  • Table 112. United Kingdom Point-of-Care Diagnostics Kit, by Prescription USD Million (2016-2021)
  • Table 113. United Kingdom Point-of-Care Diagnostics Kit, by Technology USD Million (2016-2021)
  • Table 114. United Kingdom Point-of-Care Diagnostics Kit, by End-User USD Million (2016-2021)
  • Table 115. Netherlands Point-of-Care Diagnostics Kit, by Type USD Million (2016-2021)
  • Table 116. Netherlands Point-of-Care Diagnostics Kit, by Application USD Million (2016-2021)
  • Table 117. Netherlands Point-of-Care Diagnostics Kit, by Prescription USD Million (2016-2021)
  • Table 118. Netherlands Point-of-Care Diagnostics Kit, by Technology USD Million (2016-2021)
  • Table 119. Netherlands Point-of-Care Diagnostics Kit, by End-User USD Million (2016-2021)
  • Table 120. Rest of Europe Point-of-Care Diagnostics Kit, by Type USD Million (2016-2021)
  • Table 121. Rest of Europe Point-of-Care Diagnostics Kit, by Application USD Million (2016-2021)
  • Table 122. Rest of Europe Point-of-Care Diagnostics Kit, by Prescription USD Million (2016-2021)
  • Table 123. Rest of Europe Point-of-Care Diagnostics Kit, by Technology USD Million (2016-2021)
  • Table 124. Rest of Europe Point-of-Care Diagnostics Kit, by End-User USD Million (2016-2021)
  • Table 125. MEA Point-of-Care Diagnostics Kit, by Country USD Million (2016-2021)
  • Table 126. MEA Point-of-Care Diagnostics Kit, by Type USD Million (2016-2021)
  • Table 127. MEA Point-of-Care Diagnostics Kit, by Application USD Million (2016-2021)
  • Table 128. MEA Point-of-Care Diagnostics Kit, by Prescription USD Million (2016-2021)
  • Table 129. MEA Point-of-Care Diagnostics Kit, by Technology USD Million (2016-2021)
  • Table 130. MEA Point-of-Care Diagnostics Kit, by End-User USD Million (2016-2021)
  • Table 131. Middle East Point-of-Care Diagnostics Kit, by Type USD Million (2016-2021)
  • Table 132. Middle East Point-of-Care Diagnostics Kit, by Application USD Million (2016-2021)
  • Table 133. Middle East Point-of-Care Diagnostics Kit, by Prescription USD Million (2016-2021)
  • Table 134. Middle East Point-of-Care Diagnostics Kit, by Technology USD Million (2016-2021)
  • Table 135. Middle East Point-of-Care Diagnostics Kit, by End-User USD Million (2016-2021)
  • Table 136. Africa Point-of-Care Diagnostics Kit, by Type USD Million (2016-2021)
  • Table 137. Africa Point-of-Care Diagnostics Kit, by Application USD Million (2016-2021)
  • Table 138. Africa Point-of-Care Diagnostics Kit, by Prescription USD Million (2016-2021)
  • Table 139. Africa Point-of-Care Diagnostics Kit, by Technology USD Million (2016-2021)
  • Table 140. Africa Point-of-Care Diagnostics Kit, by End-User USD Million (2016-2021)
  • Table 141. North America Point-of-Care Diagnostics Kit, by Country USD Million (2016-2021)
  • Table 142. North America Point-of-Care Diagnostics Kit, by Type USD Million (2016-2021)
  • Table 143. North America Point-of-Care Diagnostics Kit, by Application USD Million (2016-2021)
  • Table 144. North America Point-of-Care Diagnostics Kit, by Prescription USD Million (2016-2021)
  • Table 145. North America Point-of-Care Diagnostics Kit, by Technology USD Million (2016-2021)
  • Table 146. North America Point-of-Care Diagnostics Kit, by End-User USD Million (2016-2021)
  • Table 147. United States Point-of-Care Diagnostics Kit, by Type USD Million (2016-2021)
  • Table 148. United States Point-of-Care Diagnostics Kit, by Application USD Million (2016-2021)
  • Table 149. United States Point-of-Care Diagnostics Kit, by Prescription USD Million (2016-2021)
  • Table 150. United States Point-of-Care Diagnostics Kit, by Technology USD Million (2016-2021)
  • Table 151. United States Point-of-Care Diagnostics Kit, by End-User USD Million (2016-2021)
  • Table 152. Canada Point-of-Care Diagnostics Kit, by Type USD Million (2016-2021)
  • Table 153. Canada Point-of-Care Diagnostics Kit, by Application USD Million (2016-2021)
  • Table 154. Canada Point-of-Care Diagnostics Kit, by Prescription USD Million (2016-2021)
  • Table 155. Canada Point-of-Care Diagnostics Kit, by Technology USD Million (2016-2021)
  • Table 156. Canada Point-of-Care Diagnostics Kit, by End-User USD Million (2016-2021)
  • Table 157. Mexico Point-of-Care Diagnostics Kit, by Type USD Million (2016-2021)
  • Table 158. Mexico Point-of-Care Diagnostics Kit, by Application USD Million (2016-2021)
  • Table 159. Mexico Point-of-Care Diagnostics Kit, by Prescription USD Million (2016-2021)
  • Table 160. Mexico Point-of-Care Diagnostics Kit, by Technology USD Million (2016-2021)
  • Table 161. Mexico Point-of-Care Diagnostics Kit, by End-User USD Million (2016-2021)
  • Table 162. Point-of-Care Diagnostics Kit: by Type(USD/Units)
  • Table 163. Company Basic Information, Sales Area and Its Competitors
  • Table 164. Company Basic Information, Sales Area and Its Competitors
  • Table 165. Company Basic Information, Sales Area and Its Competitors
  • Table 166. Company Basic Information, Sales Area and Its Competitors
  • Table 167. Company Basic Information, Sales Area and Its Competitors
  • Table 168. Company Basic Information, Sales Area and Its Competitors
  • Table 169. Company Basic Information, Sales Area and Its Competitors
  • Table 170. Company Basic Information, Sales Area and Its Competitors
  • Table 171. Company Basic Information, Sales Area and Its Competitors
  • Table 172. Company Basic Information, Sales Area and Its Competitors
  • Table 173. Point-of-Care Diagnostics Kit: by Type(USD Million)
  • Table 174. Point-of-Care Diagnostics Kit Glucose Monitoring (Strips, Meters, and Lancets) , by Region USD Million (2022-2027)
  • Table 175. Point-of-Care Diagnostics Kit Cardiometabolic testing , by Region USD Million (2022-2027)
  • Table 176. Point-of-Care Diagnostics Kit Infectious disease testing , by Region USD Million (2022-2027)
  • Table 177. Point-of-Care Diagnostics Kit Coagulation testing , by Region USD Million (2022-2027)
  • Table 178. Point-of-Care Diagnostics Kit Pregnancy and fertility testing (Pregnancy testing, and Fertility testing) , by Region USD Million (2022-2027)
  • Table 179. Point-of-Care Diagnostics Kit Tumor / Cancer marker testing , by Region USD Million (2022-2027)
  • Table 180. Point-of-Care Diagnostics Kit Urinalysis testing , by Region USD Million (2022-2027)
  • Table 181. Point-of-Care Diagnostics Kit Cholesterol testing , by Region USD Million (2022-2027)
  • Table 182. Point-of-Care Diagnostics Kit Hematology testing , by Region USD Million (2022-2027)
  • Table 183. Point-of-Care Diagnostics Kit Drugs-of-abuse testing , by Region USD Million (2022-2027)
  • Table 184. Point-of-Care Diagnostics Kit Fecal occult testing , by Region USD Million (2022-2027)
  • Table 185. Point-of-Care Diagnostics Kit Others , by Region USD Million (2022-2027)
  • Table 186. Point-of-Care Diagnostics Kit: by Application(USD Million)
  • Table 187. Point-of-Care Diagnostics Kit Cardiometabolic testing , by Region USD Million (2022-2027)
  • Table 188. Point-of-Care Diagnostics Kit Infectious disease testing , by Region USD Million (2022-2027)
  • Table 189. Point-of-Care Diagnostics Kit Nephrology testing , by Region USD Million (2022-2027)
  • Table 190. Point-of-Care Diagnostics Kit Drug-of-Abuse (DoA) testing , by Region USD Million (2022-2027)
  • Table 191. Point-of-Care Diagnostics Kit Blood glucose testing , by Region USD Million (2022-2027)
  • Table 192. Point-of-Care Diagnostics Kit Pregnancy testing , by Region USD Million (2022-2027)
  • Table 193. Point-of-Care Diagnostics Kit Cancer biomarker testing , by Region USD Million (2022-2027)
  • Table 194. Point-of-Care Diagnostics Kit Other , by Region USD Million (2022-2027)
  • Table 195. Point-of-Care Diagnostics Kit: by Prescription(USD Million)
  • Table 196. Point-of-Care Diagnostics Kit OTC testing , by Region USD Million (2022-2027)
  • Table 197. Point-of-Care Diagnostics Kit Prescription-based testing , by Region USD Million (2022-2027)
  • Table 198. Point-of-Care Diagnostics Kit: by End-User(USD Million)
  • Table 199. Point-of-Care Diagnostics Kit Hospitals , by Region USD Million (2022-2027)
  • Table 200. Point-of-Care Diagnostics Kit Diagnostic centers , by Region USD Million (2022-2027)
  • Table 201. Point-of-Care Diagnostics Kit Research laboratories , by Region USD Million (2022-2027)
  • Table 202. Point-of-Care Diagnostics Kit Home-care settings , by Region USD Million (2022-2027)
  • Table 203. Point-of-Care Diagnostics Kit Others , by Region USD Million (2022-2027)
  • Table 204. South America Point-of-Care Diagnostics Kit, by Country USD Million (2022-2027)
  • Table 205. South America Point-of-Care Diagnostics Kit, by Type USD Million (2022-2027)
  • Table 206. South America Point-of-Care Diagnostics Kit, by Application USD Million (2022-2027)
  • Table 207. South America Point-of-Care Diagnostics Kit, by Prescription USD Million (2022-2027)
  • Table 208. South America Point-of-Care Diagnostics Kit, by Technology USD Million (2022-2027)
  • Table 209. South America Point-of-Care Diagnostics Kit, by End-User USD Million (2022-2027)
  • Table 210. Brazil Point-of-Care Diagnostics Kit, by Type USD Million (2022-2027)
  • Table 211. Brazil Point-of-Care Diagnostics Kit, by Application USD Million (2022-2027)
  • Table 212. Brazil Point-of-Care Diagnostics Kit, by Prescription USD Million (2022-2027)
  • Table 213. Brazil Point-of-Care Diagnostics Kit, by Technology USD Million (2022-2027)
  • Table 214. Brazil Point-of-Care Diagnostics Kit, by End-User USD Million (2022-2027)
  • Table 215. Argentina Point-of-Care Diagnostics Kit, by Type USD Million (2022-2027)
  • Table 216. Argentina Point-of-Care Diagnostics Kit, by Application USD Million (2022-2027)
  • Table 217. Argentina Point-of-Care Diagnostics Kit, by Prescription USD Million (2022-2027)
  • Table 218. Argentina Point-of-Care Diagnostics Kit, by Technology USD Million (2022-2027)
  • Table 219. Argentina Point-of-Care Diagnostics Kit, by End-User USD Million (2022-2027)
  • Table 220. Rest of South America Point-of-Care Diagnostics Kit, by Type USD Million (2022-2027)
  • Table 221. Rest of South America Point-of-Care Diagnostics Kit, by Application USD Million (2022-2027)
  • Table 222. Rest of South America Point-of-Care Diagnostics Kit, by Prescription USD Million (2022-2027)
  • Table 223. Rest of South America Point-of-Care Diagnostics Kit, by Technology USD Million (2022-2027)
  • Table 224. Rest of South America Point-of-Care Diagnostics Kit, by End-User USD Million (2022-2027)
  • Table 225. Asia Pacific Point-of-Care Diagnostics Kit, by Country USD Million (2022-2027)
  • Table 226. Asia Pacific Point-of-Care Diagnostics Kit, by Type USD Million (2022-2027)
  • Table 227. Asia Pacific Point-of-Care Diagnostics Kit, by Application USD Million (2022-2027)
  • Table 228. Asia Pacific Point-of-Care Diagnostics Kit, by Prescription USD Million (2022-2027)
  • Table 229. Asia Pacific Point-of-Care Diagnostics Kit, by Technology USD Million (2022-2027)
  • Table 230. Asia Pacific Point-of-Care Diagnostics Kit, by End-User USD Million (2022-2027)
  • Table 231. China Point-of-Care Diagnostics Kit, by Type USD Million (2022-2027)
  • Table 232. China Point-of-Care Diagnostics Kit, by Application USD Million (2022-2027)
  • Table 233. China Point-of-Care Diagnostics Kit, by Prescription USD Million (2022-2027)
  • Table 234. China Point-of-Care Diagnostics Kit, by Technology USD Million (2022-2027)
  • Table 235. China Point-of-Care Diagnostics Kit, by End-User USD Million (2022-2027)
  • Table 236. Japan Point-of-Care Diagnostics Kit, by Type USD Million (2022-2027)
  • Table 237. Japan Point-of-Care Diagnostics Kit, by Application USD Million (2022-2027)
  • Table 238. Japan Point-of-Care Diagnostics Kit, by Prescription USD Million (2022-2027)
  • Table 239. Japan Point-of-Care Diagnostics Kit, by Technology USD Million (2022-2027)
  • Table 240. Japan Point-of-Care Diagnostics Kit, by End-User USD Million (2022-2027)
  • Table 241. India Point-of-Care Diagnostics Kit, by Type USD Million (2022-2027)
  • Table 242. India Point-of-Care Diagnostics Kit, by Application USD Million (2022-2027)
  • Table 243. India Point-of-Care Diagnostics Kit, by Prescription USD Million (2022-2027)
  • Table 244. India Point-of-Care Diagnostics Kit, by Technology USD Million (2022-2027)
  • Table 245. India Point-of-Care Diagnostics Kit, by End-User USD Million (2022-2027)
  • Table 246. South Korea Point-of-Care Diagnostics Kit, by Type USD Million (2022-2027)
  • Table 247. South Korea Point-of-Care Diagnostics Kit, by Application USD Million (2022-2027)
  • Table 248. South Korea Point-of-Care Diagnostics Kit, by Prescription USD Million (2022-2027)
  • Table 249. South Korea Point-of-Care Diagnostics Kit, by Technology USD Million (2022-2027)
  • Table 250. South Korea Point-of-Care Diagnostics Kit, by End-User USD Million (2022-2027)
  • Table 251. Australia Point-of-Care Diagnostics Kit, by Type USD Million (2022-2027)
  • Table 252. Australia Point-of-Care Diagnostics Kit, by Application USD Million (2022-2027)
  • Table 253. Australia Point-of-Care Diagnostics Kit, by Prescription USD Million (2022-2027)
  • Table 254. Australia Point-of-Care Diagnostics Kit, by Technology USD Million (2022-2027)
  • Table 255. Australia Point-of-Care Diagnostics Kit, by End-User USD Million (2022-2027)
  • Table 256. Rest of Asia-Pacific Point-of-Care Diagnostics Kit, by Type USD Million (2022-2027)
  • Table 257. Rest of Asia-Pacific Point-of-Care Diagnostics Kit, by Application USD Million (2022-2027)
  • Table 258. Rest of Asia-Pacific Point-of-Care Diagnostics Kit, by Prescription USD Million (2022-2027)
  • Table 259. Rest of Asia-Pacific Point-of-Care Diagnostics Kit, by Technology USD Million (2022-2027)
  • Table 260. Rest of Asia-Pacific Point-of-Care Diagnostics Kit, by End-User USD Million (2022-2027)
  • Table 261. Europe Point-of-Care Diagnostics Kit, by Country USD Million (2022-2027)
  • Table 262. Europe Point-of-Care Diagnostics Kit, by Type USD Million (2022-2027)
  • Table 263. Europe Point-of-Care Diagnostics Kit, by Application USD Million (2022-2027)
  • Table 264. Europe Point-of-Care Diagnostics Kit, by Prescription USD Million (2022-2027)
  • Table 265. Europe Point-of-Care Diagnostics Kit, by Technology USD Million (2022-2027)
  • Table 266. Europe Point-of-Care Diagnostics Kit, by End-User USD Million (2022-2027)
  • Table 267. Germany Point-of-Care Diagnostics Kit, by Type USD Million (2022-2027)
  • Table 268. Germany Point-of-Care Diagnostics Kit, by Application USD Million (2022-2027)
  • Table 269. Germany Point-of-Care Diagnostics Kit, by Prescription USD Million (2022-2027)
  • Table 270. Germany Point-of-Care Diagnostics Kit, by Technology USD Million (2022-2027)
  • Table 271. Germany Point-of-Care Diagnostics Kit, by End-User USD Million (2022-2027)
  • Table 272. France Point-of-Care Diagnostics Kit, by Type USD Million (2022-2027)
  • Table 273. France Point-of-Care Diagnostics Kit, by Application USD Million (2022-2027)
  • Table 274. France Point-of-Care Diagnostics Kit, by Prescription USD Million (2022-2027)
  • Table 275. France Point-of-Care Diagnostics Kit, by Technology USD Million (2022-2027)
  • Table 276. France Point-of-Care Diagnostics Kit, by End-User USD Million (2022-2027)
  • Table 277. Italy Point-of-Care Diagnostics Kit, by Type USD Million (2022-2027)
  • Table 278. Italy Point-of-Care Diagnostics Kit, by Application USD Million (2022-2027)
  • Table 279. Italy Point-of-Care Diagnostics Kit, by Prescription USD Million (2022-2027)
  • Table 280. Italy Point-of-Care Diagnostics Kit, by Technology USD Million (2022-2027)
  • Table 281. Italy Point-of-Care Diagnostics Kit, by End-User USD Million (2022-2027)
  • Table 282. United Kingdom Point-of-Care Diagnostics Kit, by Type USD Million (2022-2027)
  • Table 283. United Kingdom Point-of-Care Diagnostics Kit, by Application USD Million (2022-2027)
  • Table 284. United Kingdom Point-of-Care Diagnostics Kit, by Prescription USD Million (2022-2027)
  • Table 285. United Kingdom Point-of-Care Diagnostics Kit, by Technology USD Million (2022-2027)
  • Table 286. United Kingdom Point-of-Care Diagnostics Kit, by End-User USD Million (2022-2027)
  • Table 287. Netherlands Point-of-Care Diagnostics Kit, by Type USD Million (2022-2027)
  • Table 288. Netherlands Point-of-Care Diagnostics Kit, by Application USD Million (2022-2027)
  • Table 289. Netherlands Point-of-Care Diagnostics Kit, by Prescription USD Million (2022-2027)
  • Table 290. Netherlands Point-of-Care Diagnostics Kit, by Technology USD Million (2022-2027)
  • Table 291. Netherlands Point-of-Care Diagnostics Kit, by End-User USD Million (2022-2027)
  • Table 292. Rest of Europe Point-of-Care Diagnostics Kit, by Type USD Million (2022-2027)
  • Table 293. Rest of Europe Point-of-Care Diagnostics Kit, by Application USD Million (2022-2027)
  • Table 294. Rest of Europe Point-of-Care Diagnostics Kit, by Prescription USD Million (2022-2027)
  • Table 295. Rest of Europe Point-of-Care Diagnostics Kit, by Technology USD Million (2022-2027)
  • Table 296. Rest of Europe Point-of-Care Diagnostics Kit, by End-User USD Million (2022-2027)
  • Table 297. MEA Point-of-Care Diagnostics Kit, by Country USD Million (2022-2027)
  • Table 298. MEA Point-of-Care Diagnostics Kit, by Type USD Million (2022-2027)
  • Table 299. MEA Point-of-Care Diagnostics Kit, by Application USD Million (2022-2027)
  • Table 300. MEA Point-of-Care Diagnostics Kit, by Prescription USD Million (2022-2027)
  • Table 301. MEA Point-of-Care Diagnostics Kit, by Technology USD Million (2022-2027)
  • Table 302. MEA Point-of-Care Diagnostics Kit, by End-User USD Million (2022-2027)
  • Table 303. Middle East Point-of-Care Diagnostics Kit, by Type USD Million (2022-2027)
  • Table 304. Middle East Point-of-Care Diagnostics Kit, by Application USD Million (2022-2027)
  • Table 305. Middle East Point-of-Care Diagnostics Kit, by Prescription USD Million (2022-2027)
  • Table 306. Middle East Point-of-Care Diagnostics Kit, by Technology USD Million (2022-2027)
  • Table 307. Middle East Point-of-Care Diagnostics Kit, by End-User USD Million (2022-2027)
  • Table 308. Africa Point-of-Care Diagnostics Kit, by Type USD Million (2022-2027)
  • Table 309. Africa Point-of-Care Diagnostics Kit, by Application USD Million (2022-2027)
  • Table 310. Africa Point-of-Care Diagnostics Kit, by Prescription USD Million (2022-2027)
  • Table 311. Africa Point-of-Care Diagnostics Kit, by Technology USD Million (2022-2027)
  • Table 312. Africa Point-of-Care Diagnostics Kit, by End-User USD Million (2022-2027)
  • Table 313. North America Point-of-Care Diagnostics Kit, by Country USD Million (2022-2027)
  • Table 314. North America Point-of-Care Diagnostics Kit, by Type USD Million (2022-2027)
  • Table 315. North America Point-of-Care Diagnostics Kit, by Application USD Million (2022-2027)
  • Table 316. North America Point-of-Care Diagnostics Kit, by Prescription USD Million (2022-2027)
  • Table 317. North America Point-of-Care Diagnostics Kit, by Technology USD Million (2022-2027)
  • Table 318. North America Point-of-Care Diagnostics Kit, by End-User USD Million (2022-2027)
  • Table 319. United States Point-of-Care Diagnostics Kit, by Type USD Million (2022-2027)
  • Table 320. United States Point-of-Care Diagnostics Kit, by Application USD Million (2022-2027)
  • Table 321. United States Point-of-Care Diagnostics Kit, by Prescription USD Million (2022-2027)
  • Table 322. United States Point-of-Care Diagnostics Kit, by Technology USD Million (2022-2027)
  • Table 323. United States Point-of-Care Diagnostics Kit, by End-User USD Million (2022-2027)
  • Table 324. Canada Point-of-Care Diagnostics Kit, by Type USD Million (2022-2027)
  • Table 325. Canada Point-of-Care Diagnostics Kit, by Application USD Million (2022-2027)
  • Table 326. Canada Point-of-Care Diagnostics Kit, by Prescription USD Million (2022-2027)
  • Table 327. Canada Point-of-Care Diagnostics Kit, by Technology USD Million (2022-2027)
  • Table 328. Canada Point-of-Care Diagnostics Kit, by End-User USD Million (2022-2027)
  • Table 329. Mexico Point-of-Care Diagnostics Kit, by Type USD Million (2022-2027)
  • Table 330. Mexico Point-of-Care Diagnostics Kit, by Application USD Million (2022-2027)
  • Table 331. Mexico Point-of-Care Diagnostics Kit, by Prescription USD Million (2022-2027)
  • Table 332. Mexico Point-of-Care Diagnostics Kit, by Technology USD Million (2022-2027)
  • Table 333. Mexico Point-of-Care Diagnostics Kit, by End-User USD Million (2022-2027)
  • Table 334. Point-of-Care Diagnostics Kit: by Type(USD/Units)
  • Table 335. Research Programs/Design for This Report
  • Table 336. Key Data Information from Secondary Sources
  • Table 337. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Point-of-Care Diagnostics Kit: by Type USD Million (2016-2021)
  • Figure 5. Global Point-of-Care Diagnostics Kit: by Application USD Million (2016-2021)
  • Figure 6. Global Point-of-Care Diagnostics Kit: by Prescription USD Million (2016-2021)
  • Figure 7. Global Point-of-Care Diagnostics Kit: by End-User USD Million (2016-2021)
  • Figure 8. South America Point-of-Care Diagnostics Kit Share (%), by Country
  • Figure 9. Asia Pacific Point-of-Care Diagnostics Kit Share (%), by Country
  • Figure 10. Europe Point-of-Care Diagnostics Kit Share (%), by Country
  • Figure 11. MEA Point-of-Care Diagnostics Kit Share (%), by Country
  • Figure 12. North America Point-of-Care Diagnostics Kit Share (%), by Country
  • Figure 13. Global Point-of-Care Diagnostics Kit: by Type USD/Units (2016-2021)
  • Figure 14. Global Point-of-Care Diagnostics Kit share by Players 2021 (%)
  • Figure 15. Global Point-of-Care Diagnostics Kit share by Players (Top 3) 2021(%)
  • Figure 16. Global Point-of-Care Diagnostics Kit share by Players (Top 5) 2021(%)
  • Figure 17. BCG Matrix for key Companies
  • Figure 18. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 19. Abbott Laboratories (United States) Revenue: by Geography 2021
  • Figure 20. Siemens Healthineers AG (Germany) Revenue, Net Income and Gross profit
  • Figure 21. Siemens Healthineers AG (Germany) Revenue: by Geography 2021
  • Figure 22. Quidel Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 23. Quidel Corporation (United States) Revenue: by Geography 2021
  • Figure 24. F. Hoffman-La Roche Ltd. (Switzerland) Revenue, Net Income and Gross profit
  • Figure 25. F. Hoffman-La Roche Ltd. (Switzerland) Revenue: by Geography 2021
  • Figure 26. Danaher Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 27. Danaher Corporation (United States) Revenue: by Geography 2021
  • Figure 28. Becton (United States) Revenue, Net Income and Gross profit
  • Figure 29. Becton (United States) Revenue: by Geography 2021
  • Figure 30. Dickinson and Company (United States) Revenue, Net Income and Gross profit
  • Figure 31. Dickinson and Company (United States) Revenue: by Geography 2021
  • Figure 32. Chembio Diagnostics (United States) Revenue, Net Income and Gross profit
  • Figure 33. Chembio Diagnostics (United States) Revenue: by Geography 2021
  • Figure 34. EKF Diagnostics (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 35. EKF Diagnostics (United Kingdom) Revenue: by Geography 2021
  • Figure 36. Trinity Biotech plc (Ireland) Revenue, Net Income and Gross profit
  • Figure 37. Trinity Biotech plc (Ireland) Revenue: by Geography 2021
  • Figure 38. Global Point-of-Care Diagnostics Kit: by Type USD Million (2022-2027)
  • Figure 39. Global Point-of-Care Diagnostics Kit: by Application USD Million (2022-2027)
  • Figure 40. Global Point-of-Care Diagnostics Kit: by Prescription USD Million (2022-2027)
  • Figure 41. Global Point-of-Care Diagnostics Kit: by End-User USD Million (2022-2027)
  • Figure 42. South America Point-of-Care Diagnostics Kit Share (%), by Country
  • Figure 43. Asia Pacific Point-of-Care Diagnostics Kit Share (%), by Country
  • Figure 44. Europe Point-of-Care Diagnostics Kit Share (%), by Country
  • Figure 45. MEA Point-of-Care Diagnostics Kit Share (%), by Country
  • Figure 46. North America Point-of-Care Diagnostics Kit Share (%), by Country
  • Figure 47. Global Point-of-Care Diagnostics Kit: by Type USD/Units (2022-2027)
Some of the key companies/manufacturers profiled in the report
  • Abbott Laboratories (United States)
  • Siemens Healthineers AG (Germany)
  • Quidel Corporation (United States)
  • F. Hoffman-La Roche Ltd. (Switzerland)
  • Danaher Corporation (United States)
  • Becton (United States)
  • Dickinson and Company (United States)
  • Chembio Diagnostics (United States)
  • EKF Diagnostics (United Kingdom)
  • Trinity Biotech plc (Ireland)
Additional players considered in the study are as follows:
Nova Biomedical (United States) , PTS Diagnostics (United States) , Sekisui Diagnostics (United States) , Thermo Fisher Scientific (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation